Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McCabe

Showing results (61-70 of 259) with videos related to

Pageof 26
Sort By:
Journal of Neurology|February 25, 2018
Increased platelet count and reticulated platelets in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic signal-negative patient subgroups: results from the HaEmostasis In carotid STenosis (HEIST) studyS J X Murphy, S T Lim, J A Kinsella, et al.
Journal of the Neurological Sciences|January 27, 2016
Continuation and adherence rates on initially-prescribed intensive secondary prevention therapy after Rapid Access Stroke Prevention (RASP) service assessmentStephen J X Murphy, Catherine A Coughlan, Oliver Tobin, et al.
Circulation|March 16, 2006
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trialMichelle O'Donoghue, David A Morrow, Marc S Sabatine, et al.
The American Journal of Cardiology|June 17, 2000
Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials)J Llevadot, R P Giugliano, C H McCabe, et al.
Journal of the American College of Cardiology|June 17, 1998
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial InfarctionD A Morrow, N Rifai, E M Antman, et al.
Case Reports in Neurology|August 7, 2010
Transesophageal Echocardiographically-Confirmed Pulmonary Vein Thrombosis in Association with Posterior Circulation InfarctionJustin A Kinsella, Allan J Maccarthy, Thomas J Kiernan, et al.
Journal of the American College of Cardiology|September 6, 2008
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysisRoberto R Giraldez, Robert P Giugliano, Satishkumar Mohanavelu, et al.
Journal of the American College of Cardiology|February 17, 2000
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudyD A Morrow, N Rifai, E M Antman, et al.
Muscle & Nerve|April 13, 2011
Progressive dysphagia in limb-girdle muscular dystrophy type 2BRichard Walsh, Fiona Hill, Niall Breslin, et al.
Irish Journal of Medical Science|January 20, 2017
Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian populationK O'Connell, L Williams, J Jones, et al.
Pageof 26

Showing results (61-70 of 259) with videos related to

Sort By:
Pageof 26
Journal of Neurology|February 25, 2018
Increased platelet count and reticulated platelets in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic signal-negative patient subgroups: results from the HaEmostasis In carotid STenosis (HEIST) studyS J X Murphy, S T Lim, J A Kinsella, et al.
Journal of the Neurological Sciences|January 27, 2016
Continuation and adherence rates on initially-prescribed intensive secondary prevention therapy after Rapid Access Stroke Prevention (RASP) service assessmentStephen J X Murphy, Catherine A Coughlan, Oliver Tobin, et al.
Circulation|March 16, 2006
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trialMichelle O'Donoghue, David A Morrow, Marc S Sabatine, et al.
The American Journal of Cardiology|June 17, 2000
Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials)J Llevadot, R P Giugliano, C H McCabe, et al.
Journal of the American College of Cardiology|June 17, 1998
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial InfarctionD A Morrow, N Rifai, E M Antman, et al.
Case Reports in Neurology|August 7, 2010
Transesophageal Echocardiographically-Confirmed Pulmonary Vein Thrombosis in Association with Posterior Circulation InfarctionJustin A Kinsella, Allan J Maccarthy, Thomas J Kiernan, et al.
Journal of the American College of Cardiology|September 6, 2008
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysisRoberto R Giraldez, Robert P Giugliano, Satishkumar Mohanavelu, et al.
Journal of the American College of Cardiology|February 17, 2000
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudyD A Morrow, N Rifai, E M Antman, et al.
Muscle & Nerve|April 13, 2011
Progressive dysphagia in limb-girdle muscular dystrophy type 2BRichard Walsh, Fiona Hill, Niall Breslin, et al.
Irish Journal of Medical Science|January 20, 2017
Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian populationK O'Connell, L Williams, J Jones, et al.
Pageof 26